Glaucoma device study ends early: what we learned
Disease control
Terminated
This study looked at the long-term safety and effectiveness of the STREAMLINE® Surgical System in people with open-angle glaucoma who had already taken part in an earlier trial. The goal was to see if the device continues to lower eye pressure safely over time. Only 17 people enr…
Sponsor: New World Medical, Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC